Logo image of JBTM

JBT MAREL CORP (JBTM) Stock Fundamental Analysis

USA - NYSE:JBTM - US4778391049 - Common Stock

135.01 USD
-1.05 (-0.77%)
Last: 9/17/2025, 8:04:00 PM
135.01 USD
0 (0%)
After Hours: 9/17/2025, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, JBTM scores 3 out of 10 in our fundamental rating. JBTM was compared to 128 industry peers in the Machinery industry. There are concerns on the financial health of JBTM while its profitability can be described as average. JBTM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year JBTM was profitable.
JBTM had a positive operating cash flow in the past year.
JBTM had positive earnings in each of the past 5 years.
Each year in the past 5 years JBTM had a positive operating cash flow.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.67%, JBTM is doing worse than 74.22% of the companies in the same industry.
Looking at the Return On Equity, with a value of -3.15%, JBTM is doing worse than 71.88% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.16%, JBTM is doing worse than 71.09% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for JBTM is below the industry average of 10.02%.
The 3 year average ROIC (5.49%) for JBTM is well above the current ROIC(1.16%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.67%
ROE -3.15%
ROIC 1.16%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

In the last couple of years the Profit Margin of JBTM has declined.
JBTM has a Operating Margin of 3.46%. This is in the lower half of the industry: JBTM underperforms 66.41% of its industry peers.
JBTM's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 35.79%, JBTM is in the better half of the industry, outperforming 65.63% of the companies in the same industry.
In the last couple of years the Gross Margin of JBTM has grown nicely.
Industry RankSector Rank
OM 3.46%
PM (TTM) N/A
GM 35.79%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), JBTM is destroying value.
Compared to 1 year ago, JBTM has about the same amount of shares outstanding.
The number of shares outstanding for JBTM has been increased compared to 5 years ago.
Compared to 1 year ago, JBTM has a worse debt to assets ratio.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

JBTM has an Altman-Z score of 1.66. This is a bad value and indicates that JBTM is not financially healthy and even has some risk of bankruptcy.
JBTM has a worse Altman-Z score (1.66) than 71.88% of its industry peers.
JBTM has a debt to FCF ratio of 6.79. This is a slightly negative value and a sign of low solvency as JBTM would need 6.79 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.79, JBTM is in line with its industry, outperforming 43.75% of the companies in the same industry.
A Debt/Equity ratio of 0.44 indicates that JBTM is not too dependend on debt financing.
JBTM has a Debt to Equity ratio (0.44) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 6.79
Altman-Z 1.66
ROIC/WACC0.12
WACC9.42%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.93 indicates that JBTM may have some problems paying its short term obligations.
With a Current ratio value of 0.93, JBTM is not doing good in the industry: 89.06% of the companies in the same industry are doing better.
A Quick Ratio of 0.53 indicates that JBTM may have some problems paying its short term obligations.
The Quick ratio of JBTM (0.53) is worse than 89.84% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.53
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

JBTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.34%, which is quite impressive.
JBTM shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.52% yearly.
Looking at the last year, JBTM shows a very strong growth in Revenue. The Revenue has grown by 64.98%.
The Revenue has been decreasing by -2.48% on average over the past years.
EPS 1Y (TTM)28.34%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%41.9%
Revenue 1Y (TTM)64.98%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%132.36%

3.2 Future

JBTM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.22% yearly.
Based on estimates for the next years, JBTM will show a small growth in Revenue. The Revenue will grow by 4.83% on average per year.
EPS Next Y18.06%
EPS Next 2Y20.79%
EPS Next 3Y22.22%
EPS Next 5YN/A
Revenue Next Year113.26%
Revenue Next 2Y49.49%
Revenue Next 3Y32.93%
Revenue Next 5Y4.83%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.85, which indicates a rather expensive current valuation of JBTM.
JBTM's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of JBTM to the average of the S&P500 Index (27.20), we can say JBTM is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 18.14, the valuation of JBTM can be described as rather expensive.
60.94% of the companies in the same industry are more expensive than JBTM, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, JBTM is valued a bit cheaper.
Industry RankSector Rank
PE 23.85
Fwd PE 18.14
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

JBTM's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. JBTM is more expensive than 75.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JBTM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 24.8
EV/EBITDA 31.3
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as JBTM's earnings are expected to grow with 22.22% in the coming years.
PEG (NY)1.32
PEG (5Y)46.07
EPS Next 2Y20.79%
EPS Next 3Y22.22%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.29%, JBTM is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.74, JBTM has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, JBTM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.29%

5.2 History

The dividend of JBTM has a limited annual growth rate of 0.48%.
JBTM has been paying a dividend for over 5 years, so it has already some track record.
JBTM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.48%
Div Incr Years0
Div Non Decr Years4
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

JBTM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
JBTM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-12.49%
EPS Next 2Y20.79%
EPS Next 3Y22.22%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

JBT MAREL CORP

NYSE:JBTM (9/17/2025, 8:04:00 PM)

After market: 135.01 0 (0%)

135.01

-1.05 (-0.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners87.99%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner Change4.08%
Market Cap7.02B
Analysts80
Price Target146.68 (8.64%)
Short Float %4.49%
Short Ratio4.57
Dividend
Industry RankSector Rank
Dividend Yield 0.29%
Yearly Dividend0.41
Dividend Growth(5Y)0.48%
DP-12.49%
Div Incr Years0
Div Non Decr Years4
Ex-Date08-18 2025-08-18 (0.1)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.06%
Min EPS beat(2)14.05%
Max EPS beat(2)14.08%
EPS beat(4)3
Avg EPS beat(4)6.06%
Min EPS beat(4)-8.58%
Max EPS beat(4)14.08%
EPS beat(8)5
Avg EPS beat(8)2.12%
EPS beat(12)9
Avg EPS beat(12)4.27%
EPS beat(16)10
Avg EPS beat(16)3.84%
Revenue beat(2)2
Avg Revenue beat(2)1.13%
Min Revenue beat(2)0.14%
Max Revenue beat(2)2.12%
Revenue beat(4)3
Avg Revenue beat(4)-0.85%
Min Revenue beat(4)-6.26%
Max Revenue beat(4)2.12%
Revenue beat(8)3
Avg Revenue beat(8)-2.8%
Revenue beat(12)3
Avg Revenue beat(12)-5.25%
Revenue beat(16)4
Avg Revenue beat(16)-4.6%
PT rev (1m)11.13%
PT rev (3m)14.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.3%
EPS NY rev (1m)4.7%
EPS NY rev (3m)4.36%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)1.48%
Revenue NY rev (1m)1.42%
Revenue NY rev (3m)2%
Valuation
Industry RankSector Rank
PE 23.85
Fwd PE 18.14
P/S 2.59
P/FCF 24.8
P/OCF 20.74
P/B 1.6
P/tB N/A
EV/EBITDA 31.3
EPS(TTM)5.66
EY4.19%
EPS(NY)7.44
Fwd EY5.51%
FCF(TTM)5.44
FCFY4.03%
OCF(TTM)6.51
OCFY4.82%
SpS52.15
BVpS84.18
TBVpS-24.97
PEG (NY)1.32
PEG (5Y)46.07
Profitability
Industry RankSector Rank
ROA -1.67%
ROE -3.15%
ROCE 1.42%
ROIC 1.16%
ROICexc 1.18%
ROICexgc 6.59%
OM 3.46%
PM (TTM) N/A
GM 35.79%
FCFM 10.44%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
ROICexc(3y)7.1%
ROICexc(5y)8.09%
ROICexgc(3y)24.27%
ROICexgc(5y)25.88%
ROCE(3y)6.33%
ROCE(5y)8.04%
ROICexcg growth 3Y-1.29%
ROICexcg growth 5Y-6.67%
ROICexc growth 3Y-5.85%
ROICexc growth 5Y-12.74%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 6.79
Debt/EBITDA 6.81
Cap/Depr 29.44%
Cap/Sales 2.04%
Interest Coverage 250
Cash Conversion 119.97%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.53
Altman-Z 1.66
F-Score3
WACC9.42%
ROIC/WACC0.12
Cap/Depr(3y)71.26%
Cap/Depr(5y)66.65%
Cap/Sales(3y)3.61%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.34%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%41.9%
EPS Next Y18.06%
EPS Next 2Y20.79%
EPS Next 3Y22.22%
EPS Next 5YN/A
Revenue 1Y (TTM)64.98%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%132.36%
Revenue Next Year113.26%
Revenue Next 2Y49.49%
Revenue Next 3Y32.93%
Revenue Next 5Y4.83%
EBIT growth 1Y-41.04%
EBIT growth 3Y-3.08%
EBIT growth 5Y-9.84%
EBIT Next Year186.42%
EBIT Next 3Y57.26%
EBIT Next 5YN/A
FCF growth 1Y322.87%
FCF growth 3Y4%
FCF growth 5Y22.04%
OCF growth 1Y132.67%
OCF growth 3Y1.15%
OCF growth 5Y16.21%